Home
Platform
- Technology
Solutions
- Clinical
- BioPharma
  - Discover BioPharma
Resources
Company
- About Us
- Leadership Team
- Investors
- Press Releases
- Blog
- Events
- Careers
- Contact
- Press Kit
- Partner With Us

Search for:

Home
Platform
- Technology
Solutions
Resources
Company
- About Us
- Leadership Team
- Investors
- Press Releases
- Blog
- Events
- Careers
- Contact
- Press Kit
- Partner With Us

Home
5

Events

LACAM, la historia de éxito de un Consorcio Genómico en Latinoamérica

En el 2018 una red de colaboradores y especialistas en cáncer en América Latina unió esfuerzos...

The SOPHiA DDM™ platform and Microsoft Azure: Accuracy in genomics

The SOPHiA DDM™ Platform and Microsoft Azure Accelerating SARS-CoV-2 research and surveillance

Confirmation d’un syndrome de Kallmann par l’étude de la segregation

Advanced germline variant analysis with the SOPHiA Platform

Comprehensive Tumor Profiling Capabilities for Actionable Insights

« Older Entries

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA Hereditary Cancer Solution, SOPHiA Myeloid Solution, SOPHiA Solid Tumor Solution are available as CE-IVD product for In Vitro Diagnostic Use in Europe, Turkey and Israel. Information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

Somatic gene variant annotations and related content have been powered by, without limitation, The Jackson Laboratory Clinical Knowledgebase (JAX-CKB™).

Platform

Technology
Genomics
Radiomics
Multimodal

Clinical

Oncology
Rare and Inherited Diseases
Cardiology
Neurology
Metabolism

BioPHARMA

BioPharma

Resources

Publications
Case Studies

Company

About Us
Team
Investors
Blog, News & Events
Careers
Contact
Press Kit

Somatic gene variant annotations and related content have been powered by, without limitation, The Jackson Laboratory Clinical Knowledgebase (JAX-CKB™).

Events

LACAM, la historia de éxito de un Consorcio Genómico en Latinoamérica

AACR

ECR

SCOPE

Festival of Genomics

PMWC – Silicon Valley

PMWC – East Coast

The SOPHiA DDM™ platform and Microsoft Azure: Accuracy in genomics

The SOPHiA DDM™ Platform and Microsoft Azure Accelerating SARS-CoV-2 research and surveillance

Confirmation d’un syndrome de Kallmann par l’étude de la segregation

Advanced germline variant analysis with the SOPHiA Platform

Comprehensive Tumor Profiling Capabilities for Actionable Insights

Platform

Clinical

BioPHARMA

RESOURCES

Company

Platform

Clinical

BioPHARMA

Resources

Company